GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Net Margin %

Inoviq (ASX:IIQ) Net Margin % : -1,579.80% (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Inoviq's Net Income for the six months ended in Dec. 2023 was A$-3.13 Mil. Inoviq's Revenue for the six months ended in Dec. 2023 was A$0.20 Mil. Therefore, Inoviq's net margin for the quarter that ended in Dec. 2023 was -1,579.80%.

The historical rank and industry rank for Inoviq's Net Margin % or its related term are showing as below:

ASX:IIQ' s Net Margin % Range Over the Past 10 Years
Min: -6568.95   Med: -2642.52   Max: -1507.18
Current: -1507.18


ASX:IIQ's Net Margin % is ranked worse than
93.21% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.37 vs ASX:IIQ: -1507.18

Inoviq Net Margin % Historical Data

The historical data trend for Inoviq's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Net Margin % Chart

Inoviq Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -2,642.52 -6,568.95 -2,253.52

Inoviq Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,989.55 -7,427.27 -3,406.71 -1,445.73 -1,579.80

Competitive Comparison of Inoviq's Net Margin %

For the Diagnostics & Research subindustry, Inoviq's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inoviq's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Net Margin % distribution charts can be found below:

* The bar in red indicates where Inoviq's Net Margin % falls into.



Inoviq Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Inoviq's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-8.969/0.398
=-2,253.52 %

Inoviq's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-3.128/0.198
=-1,579.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inoviq  (ASX:IIQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Inoviq Net Margin % Related Terms

Thank you for viewing the detailed overview of Inoviq's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Inoviq (ASX:IIQ) Business Description

Traded in Other Exchanges
N/A
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines